Impact-Insertion Applicator Improves Reliability of Skin Penetration by Solid Microneedle Arrays
Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 4
Abstract
In this study, high-density arrays (576 microneedles on a 5 × 5-mm backplate, gifted by Bosch, Germany, Stuttgart) with a microneedle length of 200 μm were used (Fig. 1 ). The microneedles were applied onto ex vivo human abdominal skin that was obtained from hospitals within 24 h after cosmetic surgery and dermatomed to a thickness of 600 μm (11). To investigate factors that influence the penetration efficiency, microneedles were applied onto the skin for 10 s with different forces (3.43–22.1 N) by applying weight rods (350–2,250 g) onto the insertion device for manual application. Also, the effect of application time (5–60 s) with a constant force (7.36 N) was investigated. Next, 15 participants (21–57 year; 10 male and 5 female) volunteered to apply a microneedle array three times onto ex vivo human skin, in a direction perpendicular to the skin surface, by using either a manual application device (Fig. 1d ), or an impact-insertion applicator at a velocity of 3 m/s (Fig. 1e ) (12). The type of microneedle application was randomly performed.
Authors and Affiliations
Koen van der Maaden, Emine Sekerdag, Wim Jiskoot, Joke Bouwstra
Regulation of Generic Drugs in Japan: the Current Situation and Future Prospects
Generic drugs are interchangeable with original proprietary drugs, as they have the same active pharmaceutical ingredients, dosage forms, strength, quality, indications, effects, directions, and dosage. The cost of gener...
Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy
The online version of this article (doi:10.1208/s12248-013-9463-9) contains supplementary material, which is available to authorized users.
Structure–Activity Relationships and Quantitative Structure–Activity Relationships for Breast Cancer Resistance Protein (ABCG2)
Breast cancer resistance protein (ABCG2), the newest ABC transporter, was discovered independently by three groups in the late 1990s. ABCG2 is widely distributed in the body with expression in the brain, intestine, and l...
Universal Immunoassay Applied During Early Development of Large Molecules to Understand Impact of Immunogenicity on Biotherapeutic Exposure
The online version of this article (doi:10.1208/s12248-012-9403-0) contains supplementary material, which is available to authorized users.
Population pharmacokinetics of S(−)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate
Carvedilol is a β1-, β1-, and α1-adrenoreceptor blocker indicated for treatment of hypertension and mild-tosevere congestive heart failure. The objective of this study was to develop and evaluate...